Company Jounce Therapeutics, Inc.
Equities
JNCE
US4811161011
Biotechnology & Medical Research
Business Summary
Number of employees: 141
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Michael Hearne
DFI | Director of Finance/CFO | - | - |
Eric Laub
IRC | Investor Relations Contact | - | 21-08-31 |
Allison Nance
LAW | General Counsel | - | 16-04-30 |
Ted Harding
HRO | Human Resources Officer | - | - |
General Counsel | - | 19-09-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kevin Tang
CEO | Chief Executive Officer | 57 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 52,635,468 | 41,318,605 ( 78.50 %) | 0 | 78.50 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+7.83% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |